Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120215009014N345Phase 2Completed
Phase 2, randomised, open-label trial in migraine comparing Propranolol plus melatonin with Propranolol alone (2 arms). Primary endpoints: Severity of headache, Nausea and vomiting and 2 more. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120215009014N345.